GlassScriptPhysician profile
Joseph A Puma
NPI 1982604914
$45,178.69
in general payments reported to CMS, 2019-2025
14 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2021: $239 · 2022: $4,475 · 2023: $25K · 2024: $4,704 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $2,251 · Travel and Lodging: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,040.00 |
| Consulting Fee | $12,533.94 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,530.00 |
| Food and Beverage | $2,251.39 |
| Travel and Lodging | $957.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,112.75 | 2023-2025 | Diamondback Peripheral, Ensite, Absolute Pro |
| Cardiovascular Systems INC. | $15,304.95 | 2019-2023 | Diamondback Peripheral |
| Siemens Medical Solutions USA, INC. | $8,527.96 | 2022-2025 | Artis Icono Floor, Cios Alpha |
| Medtronic, INC. | $284.72 | 2025 | Symplicity G3, Linq II, Minimed 780g |
| Angiodynamics, INC. | $240.86 | 2023 | Angiovac |
| Heartflow, INC. | $218.43 | 2021 | |
| Idorsia Pharmaceuticals US INC | $190.74 | 2025 | Tryvio |
| Philips North America LLC | $143.99 | 2024 | (Bk5) Azurion 5 M20 |
| Shockwave Medical, INC | $58.02 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $25.43 | 2025 | Farxiga |
| Boston Scientific Corporation | $22.10 | 2023 | |
| Amgen INC. | $20.51 | 2021 | |
| Tactile Systems Technology INC | $14.42 | 2025 | Nimbl, Flexitouch Plus |
| Acella Pharmaceuticals, LLC | $13.81 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Puma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.